Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Brittain

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Statistics in Medicine|December 6, 2011
A hierarchical rank test for crossover trials with censored dataErica Brittain, Dean Follmann
Journal of Biopharmaceutical Statistics|February 26, 2010
Noninferiority trial design and analysis with an ordered three-level categorical endpointErica Brittain, Zonghui Hu
Statistics in Medicine|November 9, 2004
A comparison of intent-to-treat and per-protocol results in antibiotic non-inferiority trialsErica Brittain, Daphne Lin
Biometrics|February 2, 2011
Minimize the use of minimization with unequal allocationMichael Proschan, Erica Brittain, Lisa Kammerman
Biometrics|August 8, 2007
Dynamic comparison of Kaplan-Meier proportions: monitoring a randomized clinical trial with a long-term binary endpointErica Brittain, Dean Follmann, Song Yang
Statistics in Medicine|September 12, 2018
Half blind superiority tests for clinical trials of anti-infective drugsDean Follmann, Erica Brittain, Keith Lumbard
Clinical Trials (London, England)|November 30, 2013
Discordant minimum inhibitory concentration analysis: a new path to licensure for anti-infective drugsDean Follmann, Erica Brittain, John H Powers
Biometrics|October 3, 2014
Combining one-sample confidence procedures for inference in the two-sample caseMichael P Fay, Michael A Proschan, Erica Brittain
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2002
The United States Food and Drug Administration and noninferiority margins in clinical trials of antimicrobial agentsJohn H Powers, David B Ross, Erica Brittain, et al.
Nature Reviews. Rheumatology|August 29, 2020
Safety and efficacy of HSCT for systemic sclerosis across clinical trialsLynette Keyes-Elstein, Erica Brittain, Ashley Pinckney, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Statistics in Medicine|December 6, 2011
A hierarchical rank test for crossover trials with censored dataErica Brittain, Dean Follmann
Journal of Biopharmaceutical Statistics|February 26, 2010
Noninferiority trial design and analysis with an ordered three-level categorical endpointErica Brittain, Zonghui Hu
Statistics in Medicine|November 9, 2004
A comparison of intent-to-treat and per-protocol results in antibiotic non-inferiority trialsErica Brittain, Daphne Lin
Biometrics|February 2, 2011
Minimize the use of minimization with unequal allocationMichael Proschan, Erica Brittain, Lisa Kammerman
Biometrics|August 8, 2007
Dynamic comparison of Kaplan-Meier proportions: monitoring a randomized clinical trial with a long-term binary endpointErica Brittain, Dean Follmann, Song Yang
Statistics in Medicine|September 12, 2018
Half blind superiority tests for clinical trials of anti-infective drugsDean Follmann, Erica Brittain, Keith Lumbard
Clinical Trials (London, England)|November 30, 2013
Discordant minimum inhibitory concentration analysis: a new path to licensure for anti-infective drugsDean Follmann, Erica Brittain, John H Powers
Biometrics|October 3, 2014
Combining one-sample confidence procedures for inference in the two-sample caseMichael P Fay, Michael A Proschan, Erica Brittain
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2002
The United States Food and Drug Administration and noninferiority margins in clinical trials of antimicrobial agentsJohn H Powers, David B Ross, Erica Brittain, et al.
Nature Reviews. Rheumatology|August 29, 2020
Safety and efficacy of HSCT for systemic sclerosis across clinical trialsLynette Keyes-Elstein, Erica Brittain, Ashley Pinckney, et al.
Pageof 4